216 related articles for article (PubMed ID: 20011050)
1. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
Ronan EO; Lee LN; Beverley PC; Tchilian EZ
PLoS One; 2009 Dec; 4(12):e8235. PubMed ID: 20011050
[TBL] [Abstract][Full Text] [Related]
2. Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
Tchilian E; Ahuja D; Hey A; Jiang S; Beverley P
Vaccine; 2013 Sep; 31(41):4624-31. PubMed ID: 23896422
[TBL] [Abstract][Full Text] [Related]
3. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
[TBL] [Abstract][Full Text] [Related]
4. Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
Beverley P; Ronan E; Lee L; Arnold I; Bolinger B; Powrie F; Tchilian E
Vaccine; 2013 Feb; 31(7):1086-93. PubMed ID: 23262169
[TBL] [Abstract][Full Text] [Related]
5. Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.
Lee LN; Baban D; Ronan EO; Ragoussis J; Beverley PC; Tchilian EZ
BMC Med Genomics; 2010 Oct; 3():46. PubMed ID: 20942964
[TBL] [Abstract][Full Text] [Related]
6.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
7. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
[TBL] [Abstract][Full Text] [Related]
8. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
9. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
[TBL] [Abstract][Full Text] [Related]
10. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
11. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.
Santosuosso M; Zhang X; McCormick S; Wang J; Hitt M; Xing Z
J Immunol; 2005 Jun; 174(12):7986-94. PubMed ID: 15944305
[TBL] [Abstract][Full Text] [Related]
14. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
[TBL] [Abstract][Full Text] [Related]
15. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
Forbes EK; Sander C; Ronan EO; McShane H; Hill AV; Beverley PC; Tchilian EZ
J Immunol; 2008 Oct; 181(7):4955-64. PubMed ID: 18802099
[TBL] [Abstract][Full Text] [Related]
17. A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice.
Khan A; Sayedahmed EE; Singh VK; Mishra A; Dorta-Estremera S; Nookala S; Canaday DH; Chen M; Wang J; Sastry KJ; Mittal SK; Jagannath C
Cell Rep Med; 2021 Aug; 2(8):100372. PubMed ID: 34467249
[TBL] [Abstract][Full Text] [Related]
18. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
19. Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to
Riccomi A; Piccaro G; Christensen D; Palma C; Andersen P; Vendetti S
Front Immunol; 2019; 10():934. PubMed ID: 31130946
[TBL] [Abstract][Full Text] [Related]
20. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
